Can this course count toward opioid-related CME requirements?

Many healthcare professionals use opioid-focused education to meet state, employer, or professional continuing education requirements. Participants should verify specific state requirements.

Does this course still count toward DEA training requirements?

Eligible practitioners may use this course to satisfy the federal 8-hour training requirement associated with DEA registration.

I already completed the MATE training and attested at my last renewal. Do I need to take it again?

No. The MATE Act training is a one-time requirement. Once you have completed the training and attested on a DEA registration or renewal, you will not be asked to attest again on future renewal cycles. Your obligation is permanently satisfied. The course provides valuable education in opioid prescribing, pain management, patient safety, and substance use disorders that may support ongoing professional development and CME needs.

DEA MATE, or the DEA’s Medication-Assisted Treatment (MAT) Expansion, is a program designed to enhance access to medication-assisted substance use treatment plans for individuals struggling with opioid use disorder. This initiative aims to address the growing opioid crisis by providing healthcare practitioners with the necessary education and resources to effectively implement MAT in their practices. MAT combines the use of medications such as methadone, buprenorphine, and naltrexone with counseling and behavioral therapies, offering a comprehensive approach to treating substance use disorders.

What is the DEA 3-day Rule?

The DEA 3-day rule is a regulation that permits practitioners to administer narcotic drugs to a patient for the purpose of relieving acute withdrawal symptoms without a standard prescription — but only for a maximum of three days. This provision is intended as a short-term bridge while longer-term arrangements, such as admission to a substance abuse treatment program, are made. The rule strictly prohibits renewals or extensions beyond the three-day period.

I'm a new provider applying for my first DEA registration. Do I still need to complete this training?

Yes. The MATE Act training requirement is permanent federal law with no expiration date. All practitioners applying for a new DEA registration must complete the 8-hour training and attest to it as part of their initial registration application, there are no exceptions. This course satisfies that requirement.

DEA MATE Opioid and Substance Use for Practitioners

Name: DEA MATE Opioid and Substance Use for Practitioners
Brand: HealthStream
SKU: 01t4V000009Cg9LQAS
Price: 149.0 USD
Availability: InStock

Courses: 1 Credit Hours: 8

This course discusses evidence-based strategies and best practices for preventing, treating, and mitigating substance use disorder (SUD) or opioid use disorder (OUD), as well as legal and ethical considerations related to effective pain management and opioid handling.

This course meets the 8-hour training requirement for DEA-registered practitioners under the Medication Access and Training Expansion (MATE) Act (Section 1263 of the Consolidated Appropriations Act of 2023). New practitioners must complete this 8-hour course before their first DEA registration is issued. Providers who have not yet attested must do so at their next renewal. Those who have already attested do not need to repeat the training.

.price-ui--loading { display: block !important; opacity: 1 !important; }

$149

Course Included

Course Topics

Foundations in Opioid Administration: Micro-Certification

Opioids and Pain Management: Micro-Certification

Opioid Misuse: Micro-Certification

Substance Use Disorder: Opioids, Treatment Approaches, and Relapse

Confidentiality of Substance Use Patient Records

Course Objectives

After completion of this course, the participant should be able to:

Recall legal requirements for opioid prescribing and handling.
Apply key recommendations and best practices, restrictions, and requirements for prescribing opioids for pain management.
Specify essential client education and conversations related to use of opioids for pain management, including safety, storage, and disposal information.
Identify how geographic, ethnic, and socioeconomic health disparities and biases affect appropriate and equitable pain assessment, treatment, and management.
Identify the best use of screening tools for substance use disorder (SUD).
Describe how to identify risk for, diagnose, and appropriately treat someone with opioid overdose, opioid use disorder (OUD), or SUD.
Evaluate the process and functions of state Prescription Drug Monitoring Programs (PDMPs).
Identify techniques for building mutual respect between the client, family, and care team responsible for treatment of OUD or SUD.
Explain potential treatment benefits and pitfalls of medication-assisted treatment (MAT) programs to treat OUD or SUD.
List strategies that align with HIPAA or the 42 CFR Part 2 (Final Rule) for maintaining the confidentiality of clients and their protected health information (PHI) while undergoing treatment for OUD or SUD.

Accreditation

HealthStream designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity. This educational offering is provided by HealthStream CNE Provider Unit. HealthStream CNE Provider Unit is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. ANCC Provider Number: P0088. This activity is awarded 8.0 contact hours; 0.0 contact hours are in pharmacology.

FAQs

: Many healthcare professionals use opioid-focused education to meet state, employer, or professional continuing education requirements. Participants should verify specific state requirements.
: Eligible practitioners may use this course to satisfy the federal 8-hour training requirement associated with DEA registration.
: No. The MATE Act training is a one-time requirement. Once you have completed the training and attested on a DEA registration or renewal, you will not be asked to attest again on future renewal cycles. Your obligation is permanently satisfied. The course provides valuable education in opioid prescribing, pain management, patient safety, and substance use disorders that may support ongoing professional development and CME needs.
: DEA MATE, or the DEA’s Medication-Assisted Treatment (MAT) Expansion, is a program designed to enhance access to medication-assisted substance use treatment plans for individuals struggling with opioid use disorder. This initiative aims to address the growing opioid crisis by providing healthcare practitioners with the necessary education and resources to effectively implement MAT in their practices. MAT combines the use of medications such as methadone, buprenorphine, and naltrexone with counseling and behavioral therapies, offering a comprehensive approach to treating substance use disorders.
: The DEA 3-day rule is a regulation that permits practitioners to administer narcotic drugs to a patient for the purpose of relieving acute withdrawal symptoms without a standard prescription — but only for a maximum of three days. This provision is intended as a short-term bridge while longer-term arrangements, such as admission to a substance abuse treatment program, are made. The rule strictly prohibits renewals or extensions beyond the three-day period.
: Yes. The MATE Act training requirement is permanent federal law with no expiration date. All practitioners applying for a new DEA registration must complete the 8-hour training and attest to it as part of their initial registration application, there are no exceptions. This course satisfies that requirement.